Post-orchiectomy adjuvant therapy versus surveillance for stage IS testicular cancer.

Authors

Sophia Kamran

Sophia C. Kamran

Harvard Radiation Oncology Program, Boston, MA

Sophia C. Kamran , Thomas Seisen , Sarah C. Markt , Mark A Preston , A. Lindsay Frazier , Christopher Sweeney , Clair Beard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer

Track

Renal Cell Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 406)

DOI

10.1200/JCO.2017.35.6_suppl.406

Abstract #

406

Poster Bd #

B23

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Excellent outcomes in bilateral testicular germ cell tumors over four decades.

Excellent outcomes in bilateral testicular germ cell tumors over four decades.

First Author: Ning-Ning Lu

First Author: Alireza Ghoreifi

Poster

2024 ASCO Genitourinary Cancers Symposium

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

First Author: Antoine Morin Coulombe

Poster

2022 ASCO Genitourinary Cancers Symposium

Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.

Evaluating the discriminatory capacity of miR-371A-3P in the context of pure seminomatous testicular cancer metastases.

First Author: Bendu Konneh